Mena FN

Advanced Renal Cell Carcinoma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, And Clinical Trial Progress Assessment By Delveinsight Molecure S.A., Daiichi Sankyo, Janux ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards ...
ascopubs.org

Update on Biomarkers in Renal Cell Carcinoma

Immune checkpoint inhibitors have significantly transformed the treatment paradigm for metastatic renal cell carcinoma (RCC), offering prolonged overall survival and achieving remarkable deep and ...
ascopubs.org

A randomized trial of radium-223 (Ra-223) dichloride and cabozantinib in patients (pts) with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL/Alliance A031801).

Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) (CaNI) for advanced renal cell carcinoma with variant histology (aRCCVH). Background: Bone metastases are prevalent in ...
Hosted on MSN

Treatment options for metastatic and recurrent renal cell carcinoma

When the kidney cancer known as renal cell carcinoma spreads to other places (metastatic) or comes back after remission (recurrent), you may need different types of treatment. Surgery can remove renal ...
National Institute for Health and Care Excellence

Quality statement 4: Surgery with curative intent

Adults with high-risk localised or locally advanced renal cell carcinoma (RCC), for whom surgery is suitable, have surgery with curative intent within 31 days of the decision to treat. Surgery with ...